# OnCo record paper-anbl0531-twist-jco-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-anbl0531-twist-jco-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-anbl0531-twist-jco-2019" ;
  schema:name "ANBL0531: response- and biology-based therapy for intermediate-risk neuroblastoma"@en ;
  schema:description "Further reducing chemotherapy according to biology and response, including observation alone for some infants, maintained a three-year survival of 96 percent in intermediate-risk neuroblastoma."@en ;
  schema:url <https://onco.cc/key-papers/paper-anbl0531-twist-jco-2019/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.19.00919>, <https://pubmed.ncbi.nlm.nih.gov/31386611/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.19.00919> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Twist CJ, Schmidt ML, Naranjo A, et al." ;
  onco:cancers <https://onco.cc/cancers/neuroblastoma-intermediate-risk/> ;
  onco:journals <https://onco.cc/journals/jco/> .